baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Call 17 DVAX 21.06.../ DE000ME74CL0 /

2024-05-09 8:48:02 PM	Chg.-	Bid10:00:35 PM	Ask10:00:35 PM	Underlying	Strike price	Expiration date	Option type
0.158EUR	-	- Bid Size: -	- Ask Size: -	Dynavax Technologies...	17.00 -	2024-06-21	Call

GlobeNewswire 2020-08-31 Dynavax to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference

GlobeNewswire 2020-08-13 Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Respon...

GlobeNewswire 2020-08-06 Dynavax Announces Second Quarter 2020 Financial Results

GlobeNewswire 2020-08-03 TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $2...

GlobeNewswire 2020-07-30 Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020

TeleTrader 2020-07-23 Dynavax, Medigen to collaborate on vaccine

GlobeNewswire 2020-07-23 Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate

GlobeNewswire 2020-07-21 Dynavax Announces the Appointment of Two New Board Members

GlobeNewswire 2020-07-16 Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate wi...

GlobeNewswire 2020-07-14 Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Medicago’s COVID-19 ...

GlobeNewswire 2020-07-10 Dynavax and Times Pharmacy Announce Partnership to Offer HEPLISAV-B® Hepatitis B Vaccine to Customer...

GlobeNewswire 2020-06-22 Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series

GlobeNewswire 2020-06-19 Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceut...

GlobeNewswire 2020-06-09 Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodial...

GlobeNewswire 2020-05-28 Dynavax to Present at the William Blair 40th Annual Growth Stock Conference

GlobeNewswire 2020-05-27 Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exe...

GlobeNewswire 2020-05-22 Dynavax Technologies Announces Pricing of $70.0 Million Public Offering of Common Stock

GlobeNewswire 2020-05-21 Dynavax Technologies Announces Proposed Public Offering of Common Stock

GlobeNewswire 2020-05-07 Dynavax Announces First Quarter 2020 Financial Results

GlobeNewswire 2020-04-28 Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergo...

GlobeNewswire 2020-04-23 Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020

TeleTrader 2020-04-22 Valneva, Dynavax join efforts to create COVID-19 vaccine

GlobeNewswire 2020-04-16 Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine

GlobeNewswire 2020-04-08 Dynavax Donates 10,000 Doses of HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] Vaccine ...

GlobeNewswire 2020-04-02 Dynavax Provides Business Update on COVID-19 Pandemic Impact

Morgan Stanley Call 17 DVAX 21.06.../ DE000ME74CL0 /

If you wish to receive reply to your feedback, please provide your email address.